Technological solutions can provide new avenues for solving global problems such as habitat destruction and resource ...

Bristol Myers Squibb's FDA nod for Breyanzi (liso-cel) in relapsed/refractory CLL/SLL boosts its CAR T-cell portfolio, ...

Zhu, Z., Verma, N., González, F., Shi, Z. D., & Huangfu, D. (2015). A CRISPR/Cas-Mediated Selection-free Knockin Strategy in Human Embryonic Stem Cells. Stem Cell ...

At the International Summit on Human Genome Editing, held in March 2023 at the Francis Crick Institute in London, Japanese ...

“Dr. Jackson studies a newly discovered CRISPR system ... enable us to manipulate an embryo or individual cells,” Cisneros says. “We use these SCNT microscopes for such techniques as reproductive ...

CRISPR technology has radically transformed genetic research, and at the forefront of this transformation is CRISPR screening ...

Why are CRISPR companies not OK? Will Robert F. Kennedy Jr. keep his promises if he's confirmed to lead the Department of ...

Gene editing promised a revolution, but biotech layoffs, stock slumps, and industry struggles reveal a stark reality: CRISPR is hard to do profitably.

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

Agriculture biotech market was valued at $93.10 billion in 2021, and is estimated to reach $214.6 billion by 2031, growing at a CAGR of 8.8% from 202 ...